Lets Talk Finances

Provoking Discussion on Personal Finance and Investing

CTLT - Catalent, Inc. ()

Overview

Company Summary


Catalent, Inc. is a global company that provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. With a focus on improving patient outcomes, Catalent assists pharmaceutical and biotech companies in accelerating their drug development and manufacturing processes.

The company operates through various business segments, including Softgel and Oral Technologies, Biologics and Specialty Drug Delivery, and Oral and Specialty Delivery. Each segment offers specialized services and technologies tailored to meet the unique requirements of different drug formulations and administration routes.

In the Softgel and Oral Technologies segment, Catalent manufactures softgel capsules, which are used for the delivery of oral medications. These capsules are known for their ease of swallowing and rapid drug release characteristics. The segment also provides various oral delivery technologies, such as Zydis orally disintegrating tablets and OptiGel bioavailability enhancement technologies.

The Biologics and Specialty Drug Delivery segment focuses on the development and production of biologics, which are drugs derived from living organisms. Catalent provides solutions for biologic development, including cell line engineering, process development, and scale-up capabilities. It also offers specialized drug delivery technologies for targeted therapies and improved patient compliance.

The Oral and Specialty Delivery segment caters to the development and manufacturing needs of consumer health products, such as over-the-counter medications, vitamins, and dietary supplements. Catalent offers formulation development, analytical testing, and clinical supply services for these products.

By leveraging its expertise in drug development and delivery, Catalent helps its customers bring innovative treatments and consumer health products to the market more efficiently. Its services encompass the entire product lifecycle, from early-stage development to commercial manufacturing and packaging.

In summary, Catalent, Inc. specializes in advanced delivery technologies and development solutions for pharmaceuticals, biologics, and consumer health products. The company's diverse capabilities aim to enhance drug efficacy, patient experience, and overall healthcare outcomes.

Notes (see all)

News